Stronger Together

Monday 17 July saw the launch of the Sub-Faculty of Clinical and Molecular Medicine (CaMM) where we heard from inaugural Dean of CaMM, Professor Eric Morand, who is relishing the opportunity to develop high-level strategic activities for the mutual benefit of the four organisations that sit within CaMM.

Following from Eric, we heard from Professor Helena Teede AM, Director of MCHRI, Professor Steve Nicholls, Director of Victorian Heart Institute, Professor Elizabeth Hartland, Director of the Hudson Institute, and Professor Peter Ebeling AO in his capacity as Interim Head of SCS.

Important takeaways

• It’s the time to think bigger
• The timing is perfect for the creation of the sub-faculty due to our massive growth in research and education
• Our collaborative histories are strong and we can capitalise on this
• We have a breadth of clinicians, researchers, and professional staff who are excited about future endeavours
• Our embedded programs, especially in gender equity, flow from human resource management to patient centricity and back again
• Our ethos of working to make the lives of patients longer, healthier and happier is endemic in everything we do
• There’s no limit to how bold we can be with our research agenda 

As Eric said, when governments and industry need to access exemplary clinical and research knowledge, their first point of contact is to be the Sub-Faculty of Clinical and Molecular Medicine at Monash University. Let’s make it happen.